Parametric Portfolio Associates’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-77,021
| Closed | -$2.9M | – | 3639 |
|
|
2021
Q1 | $2.9M | Sell |
77,021
-242,678
| -76% | -$6.05M | ﹤0.01% | 2542 |
|
|
2020
Q4 | $5.44M | Buy |
319,699
+50,462
| +19% | +$632K | ﹤0.01% | 2024 |
|
|
2020
Q3 | $1.26M | Sell |
269,237
-19,792
| -7% | -$101K | ﹤0.01% | 2773 |
|
|
2020
Q2 | $1.76M | Buy |
289,029
+228,718
| +379% | +$942K | ﹤0.01% | 2576 |
|
|
2020
Q1 | $137K | Buy |
60,311
+37,768
| +168% | +$160K | ﹤0.01% | 3658 |
|
|
2019
Q4 | $103K | Sell |
22,543
-33,771
| -60% | -$134K | ﹤0.01% | 3858 |
|
|
2019
Q3 | $218K | Buy |
56,314
+11,459
| +26% | +$62.9K | ﹤0.01% | 3677 |
|
|
2019
Q2 | $270K | Buy |
44,855
+31,173
| +228% | +$298K | ﹤0.01% | 3624 |
|
|
2019
Q1 | $183K | Sell |
13,682
-1,559
| -10% | -$17.8K | ﹤0.01% | 3733 |
|
|
2018
Q4 | $142K | Sell |
15,241
-12,864
| -46% | -$153K | ﹤0.01% | 3730 |
|
|
2018
Q3 | $391K | Sell |
28,105
-13,962
| -33% | -$208K | ﹤0.01% | 3532 |
|
|
2018
Q2 | $665K | Buy |
42,067
+6,517
| +18% | +$114K | ﹤0.01% | 3229 |
|
|
2018
Q1 | $611K | Buy |
35,550
+13,716
| +63% | +$268K | ﹤0.01% | 3249 |
|
|
2017
Q4 | $479K | Sell |
21,834
-5,055
| -19% | -$163K | ﹤0.01% | 3346 |
|
|
2017
Q3 | $1.1M | Buy |
26,889
+3,330
| +14% | +$105K | ﹤0.01% | 2986 |
|
|
2017
Q2 | $709K | Buy |
23,559
+13,642
| +138% | +$426K | ﹤0.01% | 3172 |
|
|
2017
Q1 | $358K | Sell |
9,917
-37,739
| -79% | -$1.66M | ﹤0.01% | 3368 |
|
|
2016
Q4 | $2.39M | Sell |
47,656
-2,211
| -4% | -$116K | ﹤0.01% | 2257 |
|
|
2016
Q3 | $2.62M | Buy |
49,867
+6,102
| +14% | +$291K | ﹤0.01% | 2151 |
|
|
2016
Q2 | $1.81M | Buy |
43,765
+1,101
| +3% | +$47.9K | ﹤0.01% | 2393 |
|
|
2016
Q1 | $1.73M | Buy |
42,664
+37,021
| +656% | +$1.27M | ﹤0.01% | 2521 |
|
|
2015
Q4 | $234K | Buy |
+5,643
| New | +$189K | ﹤0.01% | 3666 |
|
Parametric Portfolio Associates's FPRX Position: Q2 2021 in Review
Parametric Portfolio Associates sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 77,021 shares — an estimated $2.9M sold.
Parametric Portfolio Associates first reported a position in FPRX in Q4 2015 and held it in 22 quarters. The position peaked at $5.44M in Q4 2020. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Parametric Portfolio Associates reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Parametric Portfolio Associates sold 77,021 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $2.9M.
- Parametric Portfolio Associates first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 22 quarters.
- Parametric Portfolio Associates's Five Prime Therapeutics, Inc. position peaked at $5.44M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.